The markets advanced during the midday with the Dow gaining 32 points to 14,646 as investors turned their attention to earnings. Nasdaq rose 4 points to 3226.
On the upside
A Seeking Alpha contributor affirmed its Buy rating on Himax Technologies (Nasdaq: HIMX).
Unilife (Nasdaq: UNIS) will supply a pharmaceutical with a customized EZMix dual-chamber syringe.
First Solar (Nasdaq: FSLR) announced a record cadmium-telluride photovoltaic module conversion efficiency of 16.1%.
On the downside
Shares of Delcath Systems (Nasdaq: DCTH) continued falling after the Food and Drug Administration extended the review of the medical device maker's Melblez liver cancer treatment system.
BioCryst Pharmaceuticals (Nasdaq: BCRX) does not hold patents in China for its injectable flu treatment peramivir.
Starwood Property Trust (NYSE: STWD) priced its public offering of 26.5 million common shares at the discounted price of $27.30 per share.
In the broad market, advancing issues outpaced decliners by a margin of nearly 7 to 5 on the NYSE while decliners edged out advancers by more than 10 to 9 on Nasdaq. The broader S&P 500 index added 2 points to 1565.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here